ロード中...
ERβ alters the chemosensitivity of luminal breast cancer cells by regulating p53 function
Estrogen receptor α (ERα)-positive breast cancers tend to develop resistance to both endocrine therapy and chemotherapy. Despite recent progress in defining molecular pathways that confer endocrine resistance, the mechanisms that regulate chemotherapy response in luminal tumors remain largely elusiv...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5976481/ https://ncbi.nlm.nih.gov/pubmed/29854295 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25147 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|